{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T22:00:04Z","timestamp":1774735204382,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jpedsurg.2016.09.030","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T18:46:57Z","timestamp":1474051617000},"page":"2025-2029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida \u2013 a randomized controlled study"],"prefix":"10.1016","volume":"51","author":[{"given":"Vedarth","family":"Dash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi P.","family":"Kanojia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Samujh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00467-007-0691-z","article-title":"The neurogenic bladder: medical treatment","volume":"23","author":"Verpoorten","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s004310100741","article-title":"Bladder sphincter dysfunction in myelomeningocele","volume":"160","author":"Van Gool","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.2643","article-title":"Genetics and development of neural tube defects","volume":"220","author":"Copp","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpurol.2011.10.022","article-title":"Gabapentin: a novel drug as add-on therapy in cases of refractory overactive bladder in children","volume":"9","author":"Ansari","year":"2013","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.nrl.0000256353.14257.7c","article-title":"New look at the second-generation antiepileptic drugs: a decade of experience","volume":"13","author":"LaRoche","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00007611-200093020-00021","article-title":"Interstitial cystitis and the potential role of gabapentin","volume":"93","author":"Hansen","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(99)00063-7","article-title":"Gabapentin in childhood epilepsy. A prospective evaluation of efficacy and safety","volume":"38","author":"Korn-Merker","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-5347(05)67239-4","article-title":"The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children","volume":"164","author":"Farhat","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0050","first-page":"148","article-title":"Detrusor-sphincter dyssynergia in children with myelomeningocele: a prospective study","volume":"37","author":"van Gool","year":"1982","journal-title":"Z Kinderchir"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0055","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1464-410x.2001.02152.x","article-title":"Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida","volume":"87","author":"Ferrara","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0090-4295(97)00489-5","article-title":"Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia","volume":"51","author":"Goessl","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1569-9056(03)80559-6","article-title":"The effect of gabapentin on neurogenic detrusor over activity, a pilot study","volume":"2","author":"Carbone","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2016.09.030_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40264-012-0006-6","article-title":"Adverse reactions to gabapentin and pregabalin","volume":"36","author":"Fuzzier","year":"2013","journal-title":"Drug Saf"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816303530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816303530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:42:49Z","timestamp":1601088169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346816303530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0022346816303530"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.09.030","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida \u2013 a randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}